The No1 Ethical retailer for Books, CD’s, DVD’s & Games
30 Day Refund Guarantee

Endocannabinoids: 120 (International Review of Neurobiology): Volume 125

Endocannabinoids: 120 (International Review of Neurobiology): Volume 125

by Matthew Hill (Editor), Matthew Hill (Editor), Loren Parsons (Editor)

  • New

    Hardcover 2015

    $159.91
Synopsis

Endocannabinoids, the latest volume in the International Review of Neurobiology series is a comprehensive overview of the state-of-the-art research into the neurobiology of migraines. It reviews the current knowledge and understanding in the field, and provides a starting point for researchers and practitioners entering the field.

$159.91

Save:$22.19 (12%)

Quantity

20+ in stock

More Information

Format: Hardcover
 Pages: 352
 Publisher: Academic Press
Published: 01 Dec 2015
ISBN 10: 0128012781
ISBN 13: 9780128012789
Book Overview: This latest volume of International Review of Neurobiology gives a comprehensive overview of Endocannabinoids, providing a comprehensive overview of the state-of-the-art research in the field, the breadth of material covered is quite impressive and the quality of the scientists is high calber and their writing is very comprehensive.

Author Bio
Matthew Hill is an Assistant Professor in the Departments of Cell Biology and Anatomy and Psychiatry at the Hotchkiss Brain Institute at the University of Calgary (Canada). He was trained in Behavioral Neuroscience and Psychoneuroendocrinology at the University of British Columbia and did postdoctoral training in the laboratory of Dr. Bruce McEwen at the Rockefeller University. Dr. Hill's research has helped to reveal the critical role, and neural circuits through which, endocannabinoid signaling regulates acute responsiveness and adaptation of the stress response, both at the neuroendocrine and behavioral level. Further, his research has demonstrated how chronic stress can compromise endocannabinoid function, identifying this system as target for both the pathophysiology and treatment of stress-related mood and anxiety disorders. This research program is funded by CIHR, NSERC and Brain Canada. Dr. Hill has done consulting with Health Canada regarding their information document for health care professionals providing information on cannabis, as well as in industry where he has consulted with both Pfizer and Johnson & Johnson regarding their endocannabinoid research programs and potential applications to stress-related psychiatric illnesses.